NEW YORK, Sept. 7 (GenomeWeb News) - US biotech firm Nucleonics said today that it has filed a request with the Commissioner of Patents in Australia to re-examine the validity of an RNAi-related patent previously issued to Benitec and the Commonwealth Scientific and Industrial Research Organization.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.